Luoxin Pharmaceuticals

Luoxin Pharmaceuticals Group Joint-stock Co., Ltd. (Stock Code: 002793) is a large pharmaceutical enterprise group integrating drug research and development, production, trade, and medical health services. Since 2006, the company has continuously ranked among the Top 100 Chinese Pharmaceutical Industry enterprises, and since 2011, it has been rated as one of the Best Industrial Enterprises for Pharmaceutical R&D Product Lines in China. It is also a national industrial quality benchmarking enterprise, a national key high-tech enterprise, and a national technology innovation demonstration enterprise.

Adhering to the strategic policy of "prospering the enterprise through technology," the company has established a research center in Shanghai Zhangjiang High-Tech Park. The research team, composed of high-end domestic and international scientific and technological talents, leverages the advantageous resources within the park to undertake the R&D of high-tech projects and the cultivation of high-tech talent. Together with the headquarters, they form a trinity research system that more powerfully drives the development of new drugs. The company has established a nationally recognized enterprise technology center, a national and local joint engineering laboratory, a national post-doctoral research workstation, a "Taishan Scholar - Distinguished Expert in Pharmacy" post, a Shandong Provincial academician workstation, the Shandong Provincial Freeze-Dried Powder Injection Drug Engineering Technology Research Center, the Shandong Provincial Freeze-Dried Powder Injection Drug Engineering Laboratory, and the Shandong Provincial Key Laboratory for Freeze-Dried Powder Injection Drugs. Additionally, Shenyang Pharmaceutical University has established the Luoxin Pharmaceuticals Post-Doctoral Mobile Station, teaching training base, internship base, and graduate employment base, forming a strong research and technology center that injects vitality into the enterprise's rapid development.

· The group's 18 products have been included in the National "Major New Drug Creation" Science and Technology Major Project
· 4 products have been included in the "National Key New Product Plan"
· 12 products have been included in the "National Torch Plan"
· 144 projects have been included in the Shandong Provincial Torch Plan, Shandong Provincial Science and Technology Development Plan, and Shandong Provincial Technology Innovation Projects; multiple products have received "Science and Technology Progress Awards," among which one product technology has won the second prize of the National Science and Technology Progress Award.
· Over 200 product technologies have obtained Chinese invention patent certificates, with 20 years of patent protection.
Luoxin Group adheres to the guiding principles of integrity, innovation, and the values of "rewarding employees, rewarding customers, rewarding shareholders, rewarding society, and strengthening the enterprise," continuously creating the maximum value space needed by our customers, and insisting on facing customers with high-quality products, favorable prices, and excellent service.